Creating permissive microenvironments for stem cell transplantation into the central nervous system

Trends in Biotechnology

Volumn 30, Issue 1, 2012, Pages 55-63

  Kim, Howard ^a,b   Cooke, Michael J ^b,c   Shoichet, Molly S ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURVIVAL; CENTRAL NERVOUS SYSTEMS; DAMAGED CELLS; GROWTH FACTOR DELIVERY; HOST TISSUES; MICROENVIRONMENTS; REPAIR STRATEGY; STEM CELL THERAPY; STEM CELL TRANSPLANTATION; TRAUMATIC INJURY;

HISTOLOGY; TISSUE; TISSUE ENGINEERING;

STEM CELLS;

FIBROBLAST GROWTH FACTOR 2; POLYGLACTIN; POLYGLYCOLIDE; POLYLACTIDE; VASCULOTROPIN;

CELL ADHESION; CELL DIFFERENTIATION; CELL ENCAPSULATION; CELL GROWTH; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; DRUG DELIVERY SYSTEM; EXTRACELLULAR MATRIX; HUMAN; HYDROPHILICITY; IMMOBILIZED CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NEURAL STEM CELL; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; REVIEW; SPINAL CORD INJURY; TISSUE ENGINEERING; TRAUMATIC BRAIN INJURY; TUMOR MICROENVIRONMENT; YOUNG MODULUS;

ADULT; BIOCOMPATIBLE MATERIALS; BRAIN INJURIES; CELL DIFFERENTIATION; CELL SURVIVAL; CELLULAR MICROENVIRONMENT; GRAFT SURVIVAL; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; NEURAL STEM CELLS; STEM CELL TRANSPLANTATION;

EID: 84355166721     PISSN: 01677799     EISSN: 18793096     Source Type: Journal    
DOI: 10.1016/j.tibtech.2011.07.002     Document Type: Review

References (81)

1. Obermair F.J., et al. Endogenous neural progenitor cells as therapeutic target after spinal cord injury. Physiology (Bethesda) 2008, 23:296-304.
2. Cooke M.J., et al. Controlled epi-cortical delivery of epidermal growth factor for the stimulation of endogenous neural stem cell proliferation in stroke-injured brain. Biomaterials 2011, 32:5688-5697.
3. Ruff C.A., Fehlings M.G. Neural stem cells in regenerative medicine: bridging the gap. Panminerva Med. 2010, 52:125-147.
4. Tetzlaff W., et al. A systematic review of cellular transplantation therapies for spinal cord injury. J. Neurotrauma 2011, 28:1611-1682.
5. Morshead C.M., et al. Neural stem cells in the adult mammalian forebrain: a relatively quiescent subpopulation of subependymal cells. Neuron 1994, 13:1071-1082.
6. Palmer T.D., et al. The adult rat hippocampus contains primordial neural stem cells. Mol. Cell. Neurosci. 1997, 8:389-404.
7. Weiss S., et al. Multipotent CNS stem cells are present in the adult mammalian spinal cord and ventricular neuroaxis. J. Neurosci. 1996, 16:7599-7609.
8. Tropepe V., et al. Direct neural fate specification from embryonic stem cells: a primitive mammalian neural stem cell stage acquired through a default mechanism. Neuron 2001, 30:65-78.
9. Hu B.Y., et al. Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:4335-4340.
10. Parr A.M., et al. Transplantation of adult rat spinal cord stem/progenitor cells for spinal cord injury. J. Neurotrauma 2007, 24:835-845.
11. Tarasenko Y.I., et al. Human fetal neural stem cells grafted into contusion-injured rat spinal cords improve behavior. J. Neurosci. Res. 2007, 85:47-57.
12. Macias M.Y., et al. Pain with no gain: allodynia following neural stem cell transplantation in spinal cord injury. Exp. Neurol. 2006, 201:335-348.
13. Cote M.P., et al. Peripheral nerve grafts support regeneration after spinal cord injury. Neurotherapeutics 2011, 8:294-303.
14. Tom V.J., et al. Combining peripheral nerve grafts and chondroitinase promotes functional axonal regeneration in the chronically injured spinal cord. J. Neurosci. 2009, 29:14881-14890.
15. Williams D.F. On the nature of biomaterials. Biomaterials 2009, 30:5897-5909.
16. Heino J., Kapyla J. Cellular receptors of extracellular matrix molecules. Curr. Pharm. Des. 2009, 15:1309-1317.
17. Pradhan S., Farach-Carson M.C. Mining the extracellular matrix for tissue engineering applications. Regen. Med. 2010, 5:961-970.
18. Lu J.M., et al. Current advances in research and clinical applications of PLGA-based nanotechnology. Expert Rev. Mol. Diagn. 2009, 9:325-341.
19. Madhavan Nampoothiri K., et al. An overview of the recent developments in polylactide (PLA) research. Bioresour. Technol. 2010, 101:8493-8501.
20. Annabi N., et al. Controlling the porosity and microarchitecture of hydrogels for tissue engineering. Tissue Eng. Part B: Rev. 2010, 16:371-383.
21. Geckil H., et al. Engineering hydrogels as extracellular matrix mimics. Nanomedicine (Lond.) 2010, 5:469-484.
22. Nguyen M.K., Lee D.S. Injectable biodegradable hydrogels. Macromol. Biosci. 2010, 10:563-579.
23. Norman L.L., et al. Guiding axons in the central nervous system: a tissue engineering approach. Tissue Eng. Part B: Rev. 2009, 15:291-305.
24. Aizawa Y., et al. The effect of immobilized platelet derived growth factor AA on neural stem/progenitor cell differentiation on cell-adhesive hydrogels. Biomaterials 2008, 29:4676-4683.
25. Guarnieri D., et al. Covalently immobilized RGD gradient on PEG hydrogel scaffold influences cell migration parameters. Acta Biomater. 2010, 6:2532-2539.
26. Haile Y., et al. The effect of modified polysialic acid based hydrogels on the adhesion and viability of primary neurons and glial cells. Biomaterials 2008, 29:1880-1891.
27. Lu B., et al. Oriented immobilization of antibodies and its applications in immunoassays and immunosensors. Analyst 1996, 121:29R-32R.
28. Hu J., et al. Effects of extracellular matrix molecules on the growth properties of oligodendrocyte progenitor cells in vitro. J. Neurosci. Res. 2009, 87:2854-2862.
29. Ma W., et al. Cell-extracellular matrix interactions regulate neural differentiation of human embryonic stem cells. BMC Dev. Biol. 2008, 8:90.
30. Zvibel I., et al. Anoikis: roadblock to cell transplantation?. Cell Transplant. 2002, 11:621-630.
31. Hoffman-Kim D., et al. Topography, cell response, and nerve regeneration. Annu. Rev. Biomed. Eng. 2010, 12:203-231.
32. Aizawa Y., et al. Endothelial cell guidance in 3D patterned scaffolds. Adv. Mater. 2010, 22:4831-4835.
33. Cooke M.J., et al. Neural differentiation regulated by biomimetic surfaces presenting motifs of extracellular matrix proteins. J. Biomed. Mater. Res. A 2010, 93:824-832.
34. Guilak F., et al. Control of stem cell fate by physical interactions with the extracellular matrix. Cell Stem Cell 2009, 5:17-26.
35. Treiser M.D., et al. Cytoskeleton-based forecasting of stem cell lineage fates. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:610-615.
36. Engler A.J., et al. Matrix elasticity directs stem cell lineage specification. Cell 2006, 126:677-689.
37. Leipzig N.D., Shoichet M.S. The effect of substrate stiffness on adult neural stem cell behavior. Biomaterials 2009, 30:6867-6878.
38. Moshayedi P., et al. Mechanosensitivity of astrocytes on optimized polyacrylamide gels analyzed by quantitative morphometry. J. Phys. Condens. Matter 2010, 22:194114.
39. Fu J., et al. Mechanical regulation of cell function with geometrically modulated elastomeric substrates. Nat. Methods 2010, 7:733-736.
40. Mammoto A., Ingber D.E. Cytoskeletal control of growth and cell fate switching. Curr. Opin. Cell Biol. 2009, 21:864-870.
41. Wang N., et al. Mechanotransduction at a distance: mechanically coupling the extracellular matrix with the nucleus. Nat. Rev. Mol. Cell Biol. 2009, 10:75-82.
42. Dai X., et al. The trophic role of oligodendrocytes in the basal forebrain. J. Neurosci. 2003, 23:5846-5853.
43. Goldberg J.S., Hirschi K.K. Diverse roles of the vasculature within the neural stem cell niche. Regen. Med. 2009, 4:879-897.
44. Sun J., et al. Endothelial cells promote neural stem cell proliferation and differentiation associated with VEGF activated Notch and Pten signaling. Dev. Dyn. 2010, 239:2345-2353.
45. Schmidt N.O., et al. Vascular endothelial growth factor-stimulated cerebral microvascular endothelial cells mediate the recruitment of neural stem cells to the neurovascular niche. Brain Res. 2009, 1268:24-37.
46. Choi Y.J., et al. Enhancing trophic support of mesenchymal stem cells by ex vivo treatment with trophic factors. J. Neurol. Sci. 2010, 298:28-34.
47. Lee K., et al. Growth factor delivery-based tissue engineering: general approaches and a review of recent developments. J. R. Soc. Interface 2011, 8:153-170.
48. Pike D.B., et al. Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF. Biomaterials 2006, 27:5242-5251.
49. Baumann M.D., et al. Intrathecal delivery of a polymeric nanocomposite hydrogel after spinal cord injury. Biomaterials 2010, 31:7631-7639.
50. Rooney G.E., et al. Sustained delivery of dibutyryl cyclic adenosine monophosphate to the transected spinal cord via oligo [(polyethylene glycol) fumarate] hydrogels. Tissue Eng. Part A 2011, 17:1287-1302.
51. Kim H., et al. Design of protein-releasing chitosan channels. Biotechnol. Prog. 2008, 24:932-937.
52. Leipzig N.D., et al. Functional immobilization of interferon-gamma induces neuronal differentiation of neural stem cells. J. Biomed. Mater. Res. A 2010, 93:625-633.
53. Lappalainen R.S., et al. The SPECT imaging shows the accumulation of neural progenitor cells into internal organs after systemic administration in middle cerebral artery occlusion rats. Neurosci. Lett. 2008, 440:246-250.
54. Mothe A.J., et al. Intrathecal transplantation of stem cells by lumbar puncture for thoracic spinal cord injury in the rat. Spinal Cord 2011, 49:967-973.
55. Qu C., et al. Treatment of traumatic brain injury in mice with bone marrow stromal cell-impregnated collagen scaffolds. J. Neurosurg. 2009, 111:658-665.
56. Cooke M.J., et al. Design of biomaterials to enhance stem cell survival when transplanted into the damaged central nervous system. Soft Matter 2010, 6:4988-4998.
57. Tate C.C., et al. Laminin and fibronectin scaffolds enhance neural stem cell transplantation into the injured brain. J. Tissue Eng. Regen. Med. 2009, 3:208-217.
58. Zhong J., et al. Hydrogel matrix to support stem cell survival after brain transplantation in stroke. Neurorehabil. Neural Repair. 2010, 24:636-644.
59. Johnson P.J., et al. Tissue-engineered fibrin scaffolds containing neural progenitors enhance functional recovery in a subacute model of SCI. Soft Matter 2010, 6:5127-5137.
60. Yu D., et al. Blockade of peroxynitrite-induced neural stem cell death in the acutely injured spinal cord by drug-releasing polymer. Stem Cells 2009, 27:1212-1222.
61. Eftekharpour E., et al. Myelination of congenitally dysmyelinated spinal cord axons by adult neural precursor cells results in formation of nodes of Ranvier and improved axonal conduction. J. Neurosci. 2007, 27:3416-3428.
62. Alexanian A.R., et al. Transplantation of human glial-restricted neural precursors into injured spinal cord promotes functional and sensory recovery without causing allodynia. Cytotherapy 2011, 13:61-68.
63. Rossi S.L., et al. Histological and functional benefit following transplantation of motor neuron progenitors to the injured rat spinal cord. PLoS ONE 2010, 5:e11852.
64. Zhang Z., et al. Effects of 17beta-estradiol pre-treated adult neural stem cells on neuronal differentiation and neurological recovery in rats with cerebral ischemia. Brain Inj. 2011, 25:227-236.
65. Tang B.L., Low C.B. Genetic manipulation of neural stem cells for transplantation into the injured spinal cord. Cell Mol. Neurobiol. 2007, 27:75-85.
66. Yang J.R., et al. Directed differentiation into neural lineages and therapeutic potential of porcine embryonic stem cells in rat Parkinson's disease model. Cell Reprogram. 2010, 12:447-461.
67. Abranches E., et al. Neural differentiation of embryonic stem cells in vitro: a road map to neurogenesis in the embryo. PLoS ONE 2009, 4:e6286.
68. Hwang D.H., et al. Transplantation of human neural stem cells transduced with Olig2 transcription factor improves locomotor recovery and enhances myelination in the white matter of rat spinal cord following contusive injury. BMC Neurosci. 2009, 10:117.
69. Johnson P.J., et al. Controlled release of neurotrophin-3 and platelet-derived growth factor from fibrin scaffolds containing neural progenitor cells enhances survival and differentiation into neurons in a subacute model of SCI. Cell Transplant. 2010, 19:89-101.
70. Kim H., et al. Effects of dibutytyl cyclic-AMP on survival and neuronal differentiation of neural stem/progenitor cells transplant into spinal cord injured rats. PLoS ONE 2011, 6:e21744.
71. Ballios B.G., et al. A hydrogel-based stem cell delivery system to treat retinal degenerative diseases. Biomaterials 2010, 31:2555-2564.
72. Pritchard C.D., et al. Retinal transplantation using surface modified poly(glycerol-co-sebacic acid) membranes. Biomaterials 2011, 31:7978-7984.
73. Itosaka H., et al. Fibrin matrix provides a suitable scaffold for bone marrow stromal cells transplanted into injured spinal cord: a novel material for CNS tissue engineering. Neuropathology 2009, 29:248-257.
74. Teng Y.D., et al. Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:3024-3029.
75. Kim B.G., et al. Implantation of polymer scaffolds seeded with neural stem cells in a canine spinal cord injury model. Cytotherapy 2010, 12:841-845.
76. Pritchard C.D., et al. Establishing a model spinal cord injury in the African green monkey for the preclinical evaluation of biodegradable polymer scaffolds seeded with human neural stem cells. J. Neurosci. Methods 2010, 188:258-269.
77. Bhang S.H., et al. Basic fibroblast growth factor promotes bone marrow stromal cell transplantation-mediated neural regeneration in traumatic brain injury. Biochem. Biophys. Res. Commun. 2007, 359:40-45.
78. van Velthoven C.T., et al. Regeneration of the ischemic brain by engineered stem cells: fuelling endogenous repair processes. Brain Res. Rev. 2009, 61:1-13.
79. Rota Nodari L., et al. Long-term survival of human neural stem cells in the ischemic rat brain upon transient immunosuppression. PLoS ONE 2010, 5:e14035.
80. Cooke M.J., et al. Growth of teratomas derived from human pluripotent stem cells is influenced by the graft site. Stem Cells Dev. 2006, 15:254-259.
81. Nomura H., et al. Extramedullary chitosan channels promote survival of transplanted neural stem and progenitor cells and create a tissue bridge after complete spinal cord transection. Tissue Eng. Part A 2008, 14:649-665.